Pyrrolidine-3-carboxylic Acids as Endothelin Antagonists. 4. Side Chain Conformational Restriction Leads to ETB Selectivity
摘要:
When the dialkylacetamide side chain of the ETA-selective antagonist ABT-627 is replaced with a 2,6-dialkylacetanilide, the resultant analogues show a complete reversal of receptor selectivity, preferring ETB over ETA. By optimizing the aniline substitution pattern, as well as the alkoxy group on the 2-aryl substituent, it is possible to prepare antagonists with subnanomolar affinity for ETB and with selectivities in excess of 4000-fold. A number of these compounds also show promising pharmacokinetic profiles; a useful balance of properties is found in A-192621 (38). Pharmacology studies with A-192621 serve to reveal the role of the ETB receptor in modulating blood pressure; the observed hypertensive response to persistent ETB blockade is consistent with previous postulates and indicates that ETB-selective antagonists may not be suitable as agents for long-term systemic therapy.
The P-phenylpropa-1,2-dienyl phosphinic amides 4a-h, the corresponding phosphinates 4i-k and the (1-phenylpropa-1,2-dienyl) phosphonic diamide 4l, whose amide N-atoms resp. ester O-atoms wear unsubstituted or substituted benzene nuclei, were formed by [2,3] sigmatropic rearrangement of the corresponding (2-alkynyloxy)phosphine derivatives 3a-l. Heating the solutions of 4a-l led in some cases to decomposition
Direct and Efficient Synthesis of Pyrrole-3-carbaldehydes by Vilsmeier-Haack Formylation of Pyrroles with Sterically Crowded Amides
作者:Mikhail Kuznetsov、Petr Ilyin、Alena Pankova
DOI:10.1055/s-0031-1290763
日期:2012.5
Abstract A simple and convenient synthetic method to prepare N-substituted pyrrole-3-carbaldehydes by Vilsmeier–Haack formylation of pyrroles using stericallycrowded formamides was developed. The dependence of the formylation regioselectivity on steric features of substrates and reagents is discussed. A simple and convenient synthetic method to prepare N-substituted pyrrole-3-carbaldehydes by Vilsmeier–Haack
Aminoquinoline Derived Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use
申请人:Sun Aiming
公开号:US20110281908A1
公开(公告)日:2011-11-17
Novel classes of molecular chaperone Heat shock protein 90 (Hsp90) inhibitors and methods for making these classes are provided herein. These compounds are useful in treating and preventing cancer and other Hsp90-related diseases, such as inflammation and neurodegenerative disorders. Also provided herein are methods of treating and preventing cancer and other Hsp90 related disease. The methods include administering to a subject a therapeutically effective amount of an Hsp90 inhibitor.
PNP-type ligands enabled copper-catalyzed <i>N</i>-formylation of amines with CO<sub>2</sub> in the presence of silanes
作者:Zijie Song、Jun Liu、Shuya Xing、Xinxin Shao、Jiayun Li、Jiajian Peng、Ying Bai
DOI:10.1039/d2ob01986h
日期:——
transformation of carbondioxide into valuable fine chemicals with high efficiency is a global challenge as although CO2 is an abundant, nontoxic, and sustainable carbon feedstock it is also the most important factor behind the Greenhouse Effect. We describe herein a PNP-type ligand-enabled copper-catalyzed N-formylation of amines utilizing CO2 as the building block in the presence of hydrosilane as the reductant
将二氧化碳高效地可持续催化转化为有价值的精细化学品是一项全球性挑战,因为尽管 CO 2是一种丰富、无毒且可持续的碳原料,但它也是温室效应背后最重要的因素。我们在此描述了 PNP 型配体启用的铜催化的胺的N-甲酰化,利用 CO 2作为构建单元,在氢硅烷作为还原剂的情况下。我们目前的协议采用新合成的 PNP 型配体,在温和的反应条件下具有广泛的底物范围。
Process for the alkylation of aromatic amines and use of the products thereof
申请人:ETHYL CORPORATION
公开号:EP0148009A2
公开(公告)日:1985-07-10
A process is provided for alkylating an aromatic amine which comprises reacting at elevated temperature and in the presence of an iron oxide alkylation catalyst, an alkylatable aromatic amine with an ether co-reactive therewith whereby a portion of said ether alkylates the aromatic amine and a substantial portion of the remainder of said ether remains undecomposed. The process permits by selecting reactants and or by modifying the catalyst substantially selective orthoalkylation, N-alkylation or para-alkylation.